Yasinjan F, Xing Y, Geng H, Guo R, Yang L, Liu Z, Wang H. Immunotherapy: a promising approach for glioma treatment. Front Immunol. 2023;14:1255611. https://doi.org/10.3389/fimmu.2023.1255611. PMID: 37744349; PMCID: PMC10512462.

Article  PubMed  PubMed Central  Google Scholar 

Dao V, Yuki K, Lo YH, Nakano M, Kuo CJ. Immune organoids: from tumor modeling to precision oncology. Trends Cancer. 2022;8(10):870–80. https://doi.org/10.1016/j.trecan.2022.06.001. Epub 2022 Jun 27. PMID: 35773148; PMCID: PMC9704769.

Article  PubMed  PubMed Central  Google Scholar 

Fu C, Yu L, Miao Y, Liu X, Yu Z, Wei M. Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope? Acta Pharm Sin B. 2023;13(2):498–516. https://doi.org/10.1016/j.apsb.2022.07.020. Epub 2022 Aug 3. PMID: 36873165; PMCID: PMC9978859.

Article  PubMed  Google Scholar 

Ngo C, Garrec C, Tomasello E, Dalod M. The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond. Cell Mol Immunol. 2024 May 22. https://doi.org/10.1038/s41423-024-01167-5. Epub ahead of print. PMID: 38777879.

Grönholm M, Feodoroff M, Antignani G, Martins B, Hamdan F, Cerullo V. Patient-derived organoids for precision cancer immunotherapy. Cancer Res. 2021;81(12):3149–55. https://doi.org/10.1158/0008-5472.CAN-20-4026. Epub 2021 Mar 9. PMID: 33687948.

Article  PubMed  Google Scholar 

Byrne AT, Alférez DG, Amant F, Annibali D, Arribas J, Biankin AV, Bruna A, Budinská E, Caldas C, Chang DK, Clarke RB, Clevers H, Coukos G, Dangles-Marie V, Eckhardt SG, Gonzalez-Suarez E, Hermans E, Hidalgo M, Jarzabek MA, de Jong S, Jonkers J, Kemper K, Lanfrancone L, Mælandsmo GM, Marangoni E, Marine JC, Medico E, Norum JH, Palmer HG, Peeper DS, Pelicci PG, Piris-Gimenez A, Roman-Roman S, Rueda OM, Seoane J, Serra V, Soucek L, Vanhecke D, Villanueva A, Vinolo E, Bertotti A, Trusolino L. Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat Rev Cancer. 2017;17(4):254–268. https://doi.org/10.1038/nrc.2016.140. Epub 2017 Jan 20. Erratum in: Nat Rev Cancer. 2017;17(10):632. doi: 10.1038/nrc.2017.85. PMID: 28104906.

Yoshida GJ. Applications of patient-derived tumor xenograft models and tumor organoids. J Hematol Oncol. 2020;13(1):4. https://doi.org/10.1186/s13045-019-0829-z. PMID: 31910904; PMCID: PMC6947974.

Article  PubMed  PubMed Central  Google Scholar 

Portman N, Lim E. A new sophistication for breast cancer PDXs. Nat Cancer. 2022;3(2):138–140. https://doi.org/10.1038/s43018-021-00328-z. PMID: 35221337.

Corrò C, Novellasdemunt L, Li VSW. A brief history of organoids. Am J Physiol Cell Physiol. 2020;319(1):C151–65. https://doi.org/10.1152/ajpcell.00120.2020. Epub 2020 May 27. PMID: 32459504; PMCID: PMC7468890.

Article  PubMed  PubMed Central  Google Scholar 

Takahashi T. Organoids for drug discovery and personalized medicine. Annu Rev Pharmacol Toxicol. 2019;59:447–62. https://doi.org/10.1146/annurev-pharmtox-010818-021108. Epub 2018 Aug 16. PMID: 30113875.

Article  PubMed  Google Scholar 

Tang XY, Wu S, Wang D, Chu C, Hong Y, Tao M, Hu H, Xu M, Guo X, Liu Y. Human organoids in basic research and clinical applications. Signal Transduct Target Ther. 2022;7(1):168. https://doi.org/10.1038/s41392-022-01024-9. PMID: 35610212; PMCID: PMC9127490.

Article  PubMed  PubMed Central  Google Scholar 

LeSavage BL, Suhar RA, Broguiere N, Lutolf MP, Heilshorn SC. Next-generation cancer organoids. Nat Mater. 2022;21(2):143–59. https://doi.org/10.1038/s41563-021-01057-5. Epub 2021 Aug 12. PMID: 34385685.

Article  PubMed  Google Scholar 

de Jongh D, Massey EK. VANGUARD consortium; Bunnik EM. Organoids: a systematic review of ethical issues. Stem Cell Res Ther. 2022;13(1):337. https://doi.org/10.1186/s13287-022-02950-9. PMID: 35870991; PMCID: PMC9308907.

Article  PubMed  PubMed Central  Google Scholar 

Xu H, Jiao D, Liu A, Wu K. Tumor organoids: applications in cancer modeling and potentials in precision medicine. J Hematol Oncol. 2022;15(1):58. https://doi.org/10.1186/s13045-022-01278-4. PMID: 35551634; PMCID: PMC9103066.

Article  PubMed  PubMed Central  Google Scholar 

Hong ZX, Zhu ST, Li H, Luo JZ, Yang Y, An Y, Wang X, Wang K. Bioengineered skin organoids: from development to applications. Mil Med Res. 2023;10(1):40. https://doi.org/10.1186/s40779-023-00475-7. PMID: 37605220; PMCID: PMC10463602.

Article  PubMed  PubMed Central  Google Scholar 

Driehuis E, Kretzschmar K, Clevers H. Establishment of patient-derived cancer organoids for drug-screening applications. Nat Protoc. 2020;15(10):3380–3409. doi: 10.1038/s41596-020-0379-4. Epub 2020 Sep 14. Erratum in: Nat Protoc. 2021;16(12):5739. https://doi.org/10.1038/s41596-021-00494-5. PMID: 32929210.

Choi W, Kim YH, Woo SM, Yu Y, Lee MR, Lee WJ, Chun JW, Sim SH, Chae H, Shim H, Lee KS, Kong SY. Establishment of patient-derived organoids using ascitic or pleural fluid from cancer patients. Cancer Res Treat. 2023;55(4):1077–86. Epub 2023 Jun 12. PMID: 37309112; PMCID: PMC10582554.

Article  PubMed  PubMed Central  Google Scholar 

Mao Y, Hu H. Establishment of advanced tumor organoids with emerging innovative technologies. Cancer Lett. 2024;598:217122. https://doi.org/10.1016/j.canlet.2024.217122. Epub 2024 Jul 17. PMID.

Article  PubMed  Google Scholar 

Hu Y, Sui X, Song F, Li Y, Li K, Chen Z, Yang F, Chen X, Zhang Y, Wang X, Liu Q, Li C, Zou B, Chen X, Wang J, Liu P. Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week. Nat Commun. 2021;12(1):2581. https://doi.org/10.1038/s41467-021-22676-1. PMID: 33972544; PMCID: PMC8110811.

Article  PubMed  PubMed Central  Google Scholar 

Kratochvil MJ, Seymour AJ, Li TL, Paşca SP, Kuo CJ, Heilshorn SC. Engineered materials for organoid systems. Nat Rev Mater. 2019;4(9):606–22. https://doi.org/10.1038/s41578-019-0129-9. Epub 2019 Aug 16. PMID: 33552558; PMCID: PMC7864216.

Article  PubMed  PubMed Central  Google Scholar 

Rosenbluth JM, Schackmann RCJ, Gray GK, Selfors LM, Li CM, Boedicker M, Kuiken HJ, Richardson A, Brock J, Garber J, Dillon D, Sachs N, Clevers H, Brugge JS. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages. Nat Commun. 2020;11(1):1711. https://doi.org/10.1038/s41467-020-15548-7. PMID: 32249764; PMCID: PMC7136203.

Article  PubMed  PubMed Central  Google Scholar 

Shi R, Radulovich N, Ng C, Liu N, Notsuda H, Cabanero M, Martins-Filho SN, Raghavan V, Li Q, Mer AS, Rosen JC, Li M, Wang YH, Tamblyn L, Pham NA, Haibe-Kains B, Liu G, Moghal N, Tsao MS. Organoid cultures as preclinical models of non-small cell lung cancer. Clin Cancer Res. 2020;26(5):1162–74. https://doi.org/10.1158/1078-0432.CCR-19-1376. Epub 2019 Nov 6. PMID: 31694835.

Article  PubMed  Google Scholar 

Kim S, Choung S, Sun RX, Ung N, Hashemi N, Fong EJ, Lau R, Spiller E, Gasho J, Foo J, Mumenthaler SM. Comparison of cell and organoid-level analysis of patient-derived 3D organoids to evaluate tumor cell growth dynamics and drug response. SLAS Discov. 2020;25(7):744–54. Epub 2020 Apr 30. PMID: 32349587; PMCID: PMC7372585.

Article  PubMed  PubMed Central  Google Scholar 

Dijkstra KK, Monkhorst K, Schipper LJ, Hartemink KJ, Smit EF, Kaing S, de Groot R, Wolkers MC, Clevers H, Cuppen E, Voest EE. Challenges in establishing pure lung cancer organoids limit their utility for personalized medicine. Cell Rep. 2020;31(5):107588. https://doi.org/10.1016/j.celrep.2020.107588. PMID: 32375033.

Song J, Choi H, Koh SK, Park D, Yu J, Kang H, Kim Y, Cho D, Jeon NL. High-throughput 3D in vitro tumor vasculature model for real-time monitoring of immune cell infiltration and cytotoxicity. Front Immunol. 2021;12:733317. https://doi.org/10.3389/fimmu.2021.733317. PMID: 34630415; PMCID: PMC8500473.

Article  PubMed  PubMed Central  Google Scholar 

Magré L, Verstegen MMA, Buschow S, van der Laan LJW, Peppelenbosch M, Desai J. Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies. J Immunother Cancer. 2023;11(5):e006290. https://doi.org/10.1136/jitc-2022-006290. PMID: 37220953; PMCID: PMC10231025.

Article  PubMed  PubMed Central  Google Scholar 

Gambara G, Gaebler M, Keilholz U, Regenbrecht CRA, Silvestri A. From chemotherapy to combined targeted therapeutics: in Vitro and in vivo models to decipher intra-tumor heterogeneity. Front Pharmacol. 2018;9:77. https://doi.org/10.3389/fphar.2018.00077. PMID: 29491834; PMCID: PMC5817069.

Article  PubMed  PubMed Central  Google Scholar 

Vis MAM, Ito K, Hofmann S. Impact of culture medium on cellular interactions in in vitro co-culture systems. Front Bioeng Biotechnol. 2020;8:911. https://doi.org/10.3389/fbioe.2020.00911. PMID: 32850750; PMCID: PMC7417654.

Article  PubMed  PubMed Central  Google Scholar 

Gunti S, Hoke ATK, Vu KP, London NR Jr. Organoid and spheroid tumor models: techniques and applications. Cancers (Basel). 2021;13(4):874. https://doi.org/10.3390/cancers13040874. PMID: 33669619; PMCID: PMC7922036.

Article  PubMed  Google Scholar 

Fiorini E, Veghini L, Corbo V. Modeling cell communication in cancer with organoids: making the complex simple. Front Cell Dev Biol. 2020;8:166. https://doi.org/10.3389/fcell.2020.00166. PMID: 32258040; PMCID: PMC7094029.

Article  PubMed  PubMed Central  Google Scholar 

Schuster B, Junkin M, Kashaf SS, Romero-Calvo I, Kirby K, Matthews J, Weber CR, Rzhetsky A, White KP, Tay S. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids. Nat Commun. 2020;11(1):5271. https://doi.org/10.1038/s41467-020-19058-4. PMID: 33077832; PMCID: PMC7573629.

Article  PubMed  PubMed C